MedTrace Logo

Prioritising Patient Medication Review: Hospitals Reaching Out

NCT06451692 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 800

Last updated 2026-04-13

No results posted yet for this study

Summary

To examine the effect of a cross-sectoral medication review intervention to admitted multi-morbid, polypharmacy patients aged 65+ at SHS in two settings; an acute admission unit (typical admission time \< 48 hours) and a medical outpatient setting (patients routinely visits for follow-up, diagnosis or treatment, but do require a bed or overnight care).

Conditions

  • Medication Review
  • Polypharmacy
  • General Practitioners
  • Interdisciplinary Communication
  • Clinical Pharmacy

Interventions

OTHER

Clinical pharmacist

The clinical pharmacist calls the patients' GP 90 days after discharge for follow-up

Sponsors & Collaborators

  • University of Southern Denmark

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-06-17
Primary Completion
2027-01-01
Completion
2027-06-01

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06451692 on ClinicalTrials.gov